HCW Biologics Inc. (HCWB) earnings
Quarterly results of HCW Biologics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
HCW Biologics Inc. was expected to report around October 21, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) HCW Biologics Inc. reported revenue of $135.6K (+1,969.7% on the same quarter a year earlier) and a net loss of $5.2M.
Diluted earnings per share were -$11.58.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $135.6K | +1,969.7% | -$5.2M | -$11.58 |
| Q1 FY2026 | $6.5M | +129,080.7% | $3.5M | $1.39 |
| Q4 FY2025 | $27K | -93.2% | $719.2K | - |
| Q3 FY2025 | $15.6K | -96.3% | -$4.6M | -$2.02 |
| Q2 FY2025 | $6.6K | - | -$1.9M | -$40.72 |
| Q1 FY2025 | $5.1K | - | -$2.2M | -$11.80 |
| Q4 FY2024 | $394.8K | - | -$3.4M | - |
| Q3 FY2024 | $426.4K | - | -$3.9M | -$4.13 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report (amended) 10-Q/A
When is HCW Biologics Inc.'s next earnings date?
HCW Biologics Inc. was expected to report around October 21, 2026; nothing is on file with the SEC yet.
What were HCW Biologics Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, HCW Biologics Inc. reported revenue of $135.6K and a net loss of $5.2M. The figures come from its filing with the SEC.
Is HCW Biologics Inc.'s revenue growing?
Revenue in Q2 FY2026 was $135.6K, up 1,969.7% from $6.6K in the same quarter a year earlier.
Get an email when HCWB reports
Follow HCWB and we email you its next results the day they are filed, with the numbers explained.